Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Cardiovascular Disease
  4. Back
  5. Medical Management
  6. Rapid Aspirin Desensitisation in Patients with ACS (1166)

Rapid Aspirin Desensitisation in Patients with ACS (1166)

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 03/02/2025

Next review date: 31/12/2026

Author(s): Bik Yun Chai, Katarzyna Nowak.

Version: 2

Author email(s): katarzyna.nowak3@nhs.scot.

Approved By: Area Drug & Therapeutics: Safer Use of Medicines Committee Sub-group

Document Id: 1166

References
  • Bianco M et al. Efficacy and Safety of Available Protocols for Aspirin Hypersensitivity for Patients Undergoing Percutaneous Coronary Intervention. A Survey and Systematic Review. Pharmacology. Circulation - Cardiovascular Interventions. 2016;9:e002896.
  • Rossini R et al. Aspirin Desensitization in Patients with Coronary Artery Disease. Circulation - Cardiovascular Interventions. 2017;10:e004368.
  • Fajt ML, Petrov AA. Outpatient aspirin desensitization for patients with aspirin hypersensitivity and cardiac disease. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 2011;10:17-21.
  • Stevens WW et al. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology. Journal of Allergy and Clinical Immunology, Volume 147, Issue 3, 827 - 844.
  • Bakar SK, Niazi S. Stability of aspirin in different media. J Pharm Sci 1983;72:1024-1026.